Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Oruka Therapeutics, Inc.(ORKA) | 3,705,262 | 3,705,262 | 0 | $352.63M | $308.61M | 19.35% | -$44.02M |
| Korsana Biosciences Inc | 0 | 9,103,729 | +9,103,729 | $0 | $291.32M | 18.27% | +$291.32M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,537,191 | 2,537,191 | 0 | $247.33M | $223.40M | 14.01% | -$23.93M |
| Damora Therapeutics Inc | 0 | 8,713,000 | +8,713,000 | $0 | $185.41M | 11.63% | +$185.41M |
| Cogent Biosciences, Inc.(COGT) | 5,503,418 | 5,503,418 | 0 | $212.98M | $176.22M | 11.05% | -$36.76M |
| Viridian Therapeutics, Inc.(VRDN) | 5,090,928 | 5,090,928 | 0 | $93.52M | $104.82M | 6.57% | +$11.30M |
| Enliven Therapeutics Inc | 1,855,644 | 1,855,644 | 0 | $94.17M | $85.06M | 5.33% | -$9.11M |
| Jade Biosciences Inc | 4,553,494 | 4,553,494 | 0 | $101.18M | $63.98M | 4.01% | -$37.20M |
| Zenas BioPharma, Inc.(ZBIO) | 2,359,025 | 2,371,358 | +12,333 | $59.87M | $63.96M | 4.01% | +$4.08M |
| Crescent Biopharma, Inc.(CBIO) | 2,747,866 | 3,601,316 | +853,450 | $49.46M | $52.54M | 3.30% | +$3.08M |
| Faeth Therapeutics, Inc.(FTH) | 722,020 | 722,020 | 0 | $18.05M | $21.47M | 1.35% | +$3.42M |
| Inhibikase Therapeutics, Inc.(IKT) | 8,625,000 | 8,625,000 | 0 | $17.51M | $17.72M | 1.11% | +$215.6K |
| Apogee Therapeutics Inc | 298,647 | 0 | -298,647 | $39.64M | $0 | — | -$39.64M |
| Damora Therapeutics, Inc.(DMRA) | 8,713,000 | 0 | -8,713,000 | $226.63M | $0 | — | -$226.63M |